A phase 1 study of MDM2 inhibitor DS-3032b in patients with well/de-differentiated liposarcoma (WD/DD LPS), solid tumors (ST) and lymphomas (L) Meeting Abstract
| Authors: | Bauer, T. M.; Gounder, M. M.; Weise, A. M.; Schwartz, G. K.; Carvajal, R. D.; Kumar, P.; Zernovak, O.; Beck, A.; Doyle, J.; Mendell-Harary, J.; Kochan, J. P.; Chen, S.; LoRusso, P.; Tap, W. D.; Somaiah, N.; Hyman, D. M.; Meric-Bernstam, F.; Hong, D. S. |
| Abstract Title: | A phase 1 study of MDM2 inhibitor DS-3032b in patients with well/de-differentiated liposarcoma (WD/DD LPS), solid tumors (ST) and lymphomas (L) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 579s |
| Language: | English |
| ACCESSION: | WOS:000442916003597 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.11514 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 11514 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
